Last chance: Submit your abstracts for the 2026 #MDSCongress. https://loom.ly/22Jj9eo
Now Open:
2026 Abstract Submissions for the #MDSCongress. https://loom.ly/22Jj9eo
The abstract I presented last month at the #MDSCongress 2025 is out! I am really excited about this work and I can’t wait for the publication to be out 🤓
www.mdsabstracts.org/abstract/pre...
🌺 The EJS ACT-PD team at the #MovementDisorderCongress in Hawaii! 🌺
Members of the EJS ACT-PD team were delighted to attend the International Congress of Parkinson’s Disease and Movement Disorders in Honolulu this month.
#EJSACTPDTrial now launched to recruitment!
#MDSCongress #ParkinsonsResearch
Great photo of WPC Executive Director Eli Pollard and Josefa Domingos (Physiotherapist and past WPC speaker) at #MDSCongress in Honolulu. #Parkinsons
MDS wishes to acknowledge the following Marquee Level supporters of the 2025 International Congress: Roche and Theravance Biopharma US. #MDSCongress
MDS wishes to acknowledge the following Bronze Level supporters of the 2025 International Congress: CND Life Sciences, Dannce.ai, Encora Therapeutics, Ferrer, GE HealthCare, IntraBio, Inc., Mirum Pharma, Inc., and neuroClues. #MDSCongress
MDS wishes to acknowledge the following Bronze Level supporters of the 2025 International Congress: Amprion Inc., Association of Movement Disorder Advanced Practice Providers, BlueRock Therapeutics LP, Cala Health, Capsida Biotherapeutics, and ClearSky Medical Diagostics #MDSCongress
MDS wishes to acknowledge the following Bronze Level supporters of the 2025 International Congress: Sorridi Therapeutics, Steadiwear Inc, Theravance Biopharma US, UCB, uMed, and Yoda Pharmaceuticals Inc. #MDSCongress
MDS wishes to acknowledge the following Silver Level supporters of the 2025 International Congress: Abbott, Britannia Pharmaceuticals Ltd., Emalex Biosciences, Insightec, Ipsen Biopharmaceuticals, Inc., and Teva Pharmaceuticals. #MDSCongress
MDS wishes to acknowledge the following Gold Level supporters of the 2025 International Congress: Boston Scientific and PTC Therapeutics. #MDSCongress
MDS wishes to acknowledge the following Platinum Level supporters of the 2025 International Congress: Acadia Pharmaceuticals Inc., AskBio Inc., Biogen, H Lundbeck A/S, Medtronic, Merz Theraputics GmbH, and Supernus Pharmaceuticals. #MDSCongress
MDS wishes to acknowledge the following Diamond Level supporters of the 2025 International Congress: Amneal Pharmaceuticals and Abbvie. #MDSCongress
So excited for the Parkinson’s Disease course at #MDSCongress
#MDSCongress experts will review the most impactful recent publications in both clinical and basic neuroscience. Mdscongress.org
Did you know Movement Disorders the first-ever video journal? Discover how this innovation helped establish consensus, and the field itself.
Join us at the #MDSCongress as we celebrate the past and build the future. Mdscongress.org
2025 #MDSCongress controversy debates: Learn how to make a more informed choice when sharing research results with patients and how a biologically-based definition of PD may or may not accelerate therapeutic discovery. Mdscongress.org
Celebrating 40 Years of MDS — and the Women Who Paved the Way
As we reflect on the history of MDS, we honor the extraordinary women who shaped not only our science but our community. Join us to celebrate 40 years of MDS at the #MDSCongress. Mdscongress.org
Attend the Video Challenge, MDS’s most popular event, at the #MDSCongress. Register today. mdscongress.org
Looking forward to seeing you at the @movedisorder.bsky.social congress, the greatest gathering of movement disorders specialists on earth! #MDSCongress
@ecebayram.bsky.social
This year’s #mdscongress theme celebrates the future of disease-modifying therapies and the many areas of investigation designated to achieving this goal within the field of PD.
From standardizing PSP diagnosis to advancing therapeutic trials, the field of Movement Disorders has never stood still.
Celebrate 40 years of impact and discovery at the #MDSCongress. mdscongress.org
In the early days of Movement Disorders, clinicians and researchers gathered to watch films of patients, debating the phenomenology of complex cases.
Celebrate the legacy and future of MDS at the #MDSCongress: mdscongress.org
What sessions are you most excited for? #MDSCongress https://loom.ly/WyQTzYA
40 years ago, at a “clandestine” late-night meeting in a Hamburg hotel room, the Movement Disorder Society was born.
Celebrate 40 years of MDS at the #MDSCongress: mdscongress.org
#MDSCongress keynote lecture: Prof. Sergiu Pașca, a pioneer in the lab-based study of stem cell-derived neural circuitry that has led to astounding discoveries in fundamental brain biology. Mdscongress.org
“MDS is basically responsible for forming a subspecialty that has been the poster child for advances in treatment in neurological diseases for many years.”
Join the celebration at the #MDSCongress and be part of the next chapter: mdscongress.org
From Prof. C. David Marsden’s pivotal address at the 1993 AAN meeting to an explosion of global interest, the last 40 years have transformed how we understand and treat movement disorders.
Join us at the #MDSCongress as we celebrate the field of Movement Disorder's history. mdscongress.org